Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:35PM CDT
MXIM: 35.00 (-0.19), AWAY: 32.27 (+0.76), GHL: 42.42 (-0.33), HBHC: 30.03 (+0.25), HWAY: 18.99 (-0.08), DV: 36.49 (+0.22), RGA: 93.16 (+0.14), FET: 21.65 (+0.74), GOOG: 539.36 (+5.39), COF: 81.76 (+0.23), FII: 34.50 (+0.44), MSFT: 42.99 (+0.36), BLDR: 13.00 (-0.09), EFII: 42.55 (+0.56), BCR: 175.09 (+0.24), LSTR: 65.26 (+0.57), ETH: 25.96 (+0.16), QDEL: 23.80 (+0.64), RSG: 39.75 (+0.16), HUBG: 37.84 (+0.04), BGS: 29.77 (-0.18), DGII: 9.40 (+0.11), PFG: 51.73 (+0.73), CPHD: 53.14 (-0.78), NTGR: 33.15 (+0.57), FSL: 41.53 (+0.49), ALTR: 42.78 (-0.46), CB: 99.30 (-0.44), N: 95.42 (+1.53), MTSN: 3.73 (+0.07), JNPR: 24.39 (+0.22), MXWL: 6.94 (-0.13), FR: 20.19 (-0.10), GIMO: 23.51 (+0.29), ELY: 9.83 (-0.23), P: 17.51 (+0.28), S: 5.08 (+0.10), RMD: 73.28 (+0.17), BJRI: 50.54 (-1.00), PEB: 45.45 (-0.08), FICO: 92.00 (-0.15), ETFC: 28.60 (+1.07), HBI: 34.12 (+0.23), CBI: 49.62 (-1.62), AMZN: 389.80 (-1.38), ALGN: 55.94 (-0.21), ACTG: 9.83 (-0.08), HA: 22.02 (-0.20), KN: 21.27 (-0.24), NEM: 22.77 (-0.74), MSCC: 35.98 (-0.16), CYN: 93.19 (+0.06), CVTI: 34.35 (-0.01), RHI: 59.59 (+0.30), QLIK: 33.68 (+0.31), MKTO: 28.84 (+0.98), BAS: 7.88 (+0.07), KLAC: 60.30 (+0.96), MMSI: 18.79 (+0.45)
Uptrend Call Working As Merit Medical Systems Stock Rises 30.7% (MMSI)
Comtex SmarTrend(R) - Thu Apr 16, 4:53PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on October 24th, 2014 at $14.60. In approximately 6 months, Merit Medical Systems has returned 30.73% as of today's recent price of $19.08.
MMSI: 18.79 (+0.45)
Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2015
GlobeNewswire - Thu Apr 16, 8:30AM CDT
Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, announced today that the Company will release its financial results for the first quarter ended March 31, 2015, after the close of the stock market on Thursday, April 23, 2015.
MMSI: 18.79 (+0.45)
Will STERIS' Synergy Health Deal Facilitate Growth Further? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:10PM CDT
The Synergy health buyout should boost STERIS' (STE) presence in the international market as it will combine the company's strong presence in North America with Synergy's solid foothold across Europe.
ABC: 113.81 (-0.08), STE: 70.43 (+0.23), LH: 126.26 (+0.35), MMSI: 18.79 (+0.45)
LabCorp Boosts Specialty Testing with Forensics Partnership - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 3:58PM CDT
Bode Cellmark Forensics, a wholly-owned subsidiary of Laboratory Corporation of America Holdings (LH) recently tied up with the Committee on Missing Persons (CMP).
ABC: 113.81 (-0.08), CAH: 91.50 (+1.15), LH: 126.26 (+0.35), MMSI: 18.79 (+0.45)
Shares of MMSI Up 30.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 09, 11:12AM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on October 24th, 2014 at $14.60. In approximately 6 months, Merit Medical Systems has returned 30.32% as of today's recent price of $19.02.
MMSI: 18.79 (+0.45)
Merit Medical Systems Shares Up 31.6% Since SmarTrend's Buy Recommendation (MMSI)
Comtex SmarTrend(R) - Thu Apr 02, 9:44AM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on October 24th, 2014 at $14.60. In approximately 5 months, Merit Medical Systems has returned 31.55% as of today's recent price of $19.20.
MMSI: 18.79 (+0.45)
Why Merit Medical (MMSI) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 7:48AM CDT
Merit Medical (MMSI) has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports
MMSI: 18.79 (+0.45)
Is Becton, Dickinson Mulling the Sale of its Respiratory Unit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 2:40PM CDT
Becton, Dickinson and Company (BDX), commonly known as BD, is contemplating the sale of its respiratory devices unit.
BDX: 144.33 (-1.24), INGN: 36.39 (-0.04), MMSI: 18.79 (+0.45), MCO: 107.23 (+1.24)
Merit Medical Systems Shares Up 28.5% Since SmarTrend's Buy Recommendation (MMSI)
Comtex SmarTrend(R) - Wed Mar 25, 4:47PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on October 24th, 2014 at $14.60. In approximately 5 months, Merit Medical Systems has returned 28.47% as of today's recent price of $18.75.
MMSI: 18.79 (+0.45)
Cerner & Intermountain Healthcare Launch iCentra EHR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 3:20PM CDT
Building upon their multi-year strategic partnership, Cerner Corp (CERN) and Intermountain Healthcare implemented iCentra EHR at two Intermountain hospitals and 24 clinics across northern Utah.
ABC: 113.81 (-0.08), CAH: 91.50 (+1.15), MMSI: 18.79 (+0.45), CERN: 72.41 (+0.19)
Cerner Inks Agreement to Digitize Healthcare in Washington - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 1:30PM CDT
Cerner Corp (CERN) was selected by the State of Washington Department of Social and Health Services to modernize integrated revenue cycle and electronic health records across multiple state facilities.
CAH: 91.50 (+1.15), MRGE: 5.57 (+0.06), MMSI: 18.79 (+0.45), CERN: 72.41 (+0.19)
DENTSPLY: Product Portfolio Strong, Currency Woes Remain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 10:20AM CDT
With significant international presence, we believe that DENTSPLY International Inc. (XRAY) is going to be hurt by unfavorable currency volatility.
MCK: 231.27 (-0.02), CAH: 91.50 (+1.15), XRAY: 52.33 (+0.47), MMSI: 18.79 (+0.45)
CONMED: Strong Sell on Dismal Q4 Results, Estimate Revision - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 18, 12:10PM CDT
On Mar 18, 2015, Zacks Investment Research downgraded CONMED Corp (CNMD) to a Zacks Rank #5 (Strong Sell).
MCK: 231.27 (-0.02), CAH: 91.50 (+1.15), CNMD: 49.35 (+0.36), MMSI: 18.79 (+0.45)
Becton, Dickinson & CareFusion Unite; Moody's Not Happy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 18, 11:40AM CDT
Upon completion of the acquisition, CareFusion became a wholly-owned subsidiary of Becton, Dickinson and Company (BDX) and will now cease trading on the New York Stock Exchange.
BDX: 144.33 (-1.24), CAH: 91.50 (+1.15), MMSI: 18.79 (+0.45), MCO: 107.23 (+1.24)
Merit Medical Systems Up 34.2% Since SmarTrend Uptrend Call (MMSI)
Comtex SmarTrend(R) - Wed Mar 18, 11:21AM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on October 24th, 2014 at $14.60. In approximately 5 months, Merit Medical Systems has returned 34.16% as of today's recent price of $19.58.
MMSI: 18.79 (+0.45)
LabCorp Boosts Specialty Testing with Two New Studies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) recently announced two new studies characterizing Chronic Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV) antiviral drug resistance.
MCK: 231.27 (-0.02), CAH: 91.50 (+1.15), LH: 126.26 (+0.35), MMSI: 18.79 (+0.45)
European Regulator Oks Becton, Dickinson-CareFusion Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 16, 12:10PM CDT
Becton, Dickinson and Company (BDX) recently received European Commission's approval for its pending acquisition of CareFusion Corp (CFN).
BDX: 144.33 (-1.24), CAH: 91.50 (+1.15), CFN: 59.91 (-0.06), MMSI: 18.79 (+0.45)
Merit Medical Posts Impressive Q4, Issues View for 3 Fiscals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 1:20PM CDT
Merit Medical Systems Inc. (MMSI) recently reported an impressive fourth-quarter 2014 and provided guidance for the next 3 fiscals
ABMD: 69.31 (-0.40), INGN: 36.39 (-0.04), MMSI: 18.79 (+0.45), AFFX: 12.57 (-0.13)
Invacare Cut to Strong Sell on Dismal Q4, Should You Dump? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 12:20PM CDT
On Mar 12, 2015, Zacks Investment Research downgraded Invacare Corp. (IVC) to a Zacks Rank #5 (Strong Sell).
MCK: 231.27 (-0.02), IVC: 19.80 (+0.24), CAH: 91.50 (+1.15), MMSI: 18.79 (+0.45)